chr11-72230168-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The ENST00000298229.7(INPPL1):āc.987A>Gā(p.Ser329=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.207 in 1,610,878 control chromosomes in the GnomAD database, including 39,762 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.28 ( 7134 hom., cov: 33)
Exomes š: 0.20 ( 32628 hom. )
Consequence
INPPL1
ENST00000298229.7 synonymous
ENST00000298229.7 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.77
Genes affected
INPPL1 (HGNC:6080): (inositol polyphosphate phosphatase like 1) The protein encoded by this gene is an SH2-containing 5'-inositol phosphatase that is involved in the regulation of insulin function. The encoded protein also plays a role in the regulation of epidermal growth factor receptor turnover and actin remodelling. Additionally, this gene supports metastatic growth in breast cancer and is a valuable biomarker for breast cancer. [provided by RefSeq, Jan 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 11-72230168-A-G is Benign according to our data. Variant chr11-72230168-A-G is described in ClinVar as [Benign]. Clinvar id is 1170422.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-72230168-A-G is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-2.77 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.471 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
INPPL1 | NM_001567.4 | c.987A>G | p.Ser329= | synonymous_variant | 9/28 | ENST00000298229.7 | NP_001558.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
INPPL1 | ENST00000298229.7 | c.987A>G | p.Ser329= | synonymous_variant | 9/28 | 1 | NM_001567.4 | ENSP00000298229 | P1 | |
INPPL1 | ENST00000538751.5 | c.261A>G | p.Ser87= | synonymous_variant | 8/27 | 1 | ENSP00000444619 | |||
INPPL1 | ENST00000540329.5 | c.171A>G | p.Ser57= | synonymous_variant | 6/7 | 3 | ENSP00000440018 |
Frequencies
GnomAD3 genomes AF: 0.276 AC: 41943AN: 152140Hom.: 7131 Cov.: 33
GnomAD3 genomes
AF:
AC:
41943
AN:
152140
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.243 AC: 60662AN: 249322Hom.: 8573 AF XY: 0.242 AC XY: 32583AN XY: 134660
GnomAD3 exomes
AF:
AC:
60662
AN:
249322
Hom.:
AF XY:
AC XY:
32583
AN XY:
134660
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.199 AC: 290834AN: 1458620Hom.: 32628 Cov.: 35 AF XY: 0.203 AC XY: 146981AN XY: 725010
GnomAD4 exome
AF:
AC:
290834
AN:
1458620
Hom.:
Cov.:
35
AF XY:
AC XY:
146981
AN XY:
725010
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.276 AC: 41980AN: 152258Hom.: 7134 Cov.: 33 AF XY: 0.279 AC XY: 20771AN XY: 74444
GnomAD4 genome
AF:
AC:
41980
AN:
152258
Hom.:
Cov.:
33
AF XY:
AC XY:
20771
AN XY:
74444
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1318
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 19, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Opsismodysplasia Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 19, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at